Pulmonary tuberculosis is a bacterial infection that primarily affects the lungs. Diagnosis may involve sputum testing, molecular investigations and chest imaging. Treatment requires an appropriate combination of anti-tuberculosis medicines, with regular monitoring for treatment response and medication-related complications.
Drug-resistant tuberculosis occurs when tuberculosis bacteria are resistant to one or more commonly used medicines. Treatment requires appropriate resistance testing, specialist medication selection and careful follow-up to monitor effectiveness and potential adverse effects.
Extrapulmonary tuberculosis affects organs outside the lungs, such as lymph nodes, bones or other tissues. Diagnosis depends on the affected organ and may involve imaging, laboratory tests and tissue sampling. Treatment is selected according to disease characteristics and medical guidance.
Severe asthma may cause persistent breathing difficulties despite standard treatment. Assessment includes reviewing symptoms, inhaler technique, triggers, lung function and associated conditions. Management may involve optimized inhaled medicines and additional specialist therapies for eligible patients.
Chronic obstructive pulmonary disease causes persistent airflow limitation, commonly associated with smoking or other respiratory exposures. Treatment may include inhaled medicines, vaccination, smoking cessation support and pulmonary rehabilitation according to disease severity.
Interstitial lung diseases include conditions that affect the supporting tissues of the lungs and may lead to inflammation or scarring. Diagnosis may require high-resolution chest CT, pulmonary function tests and additional investigations to determine appropriate management.
Sleep-related breathing disorders may cause snoring, interrupted breathing and excessive daytime sleepiness. Assessment considers symptoms and associated medical conditions, with sleep studies recommended when clinically appropriate.
Pulmonary infections can involve the airways or lung tissue and may cause fever, cough, sputum production or breathing difficulties. Treatment depends on the likely infectious cause, illness severity and relevant diagnostic findings.
Some patients experience persistent respiratory symptoms after COVID-19, including breathlessness, cough and reduced exercise tolerance. Evaluation may involve clinical assessment, lung function testing and imaging when indicated to guide recovery and rehabilitation.
Bronchoscopy uses a flexible camera to examine the airways and collect selected diagnostic samples. It may be recommended for persistent respiratory symptoms, suspected airway abnormalities or infections requiring additional investigation.
Pulmonary critical care involves managing serious respiratory conditions that may require intensive hospital monitoring, oxygen support or mechanical ventilation. Treatment depends on the underlying illness and the severity of respiratory impairment.
Persistent cough and breathlessness may result from asthma, COPD, infections, interstitial lung disease or other conditions. Evaluation includes medical history, physical examination and appropriate respiratory or cardiovascular investigations.